| Mutagrip, Suspension zur Injektion - 0.5 ml | | 00373017 | | Sanofi-Aventis (Suisse) SA | | Mutagrip, Suspension zur Injektion | | 24.09.1975 | | | | | 21.08.2009 | | Influenza, gereinigtes Antigen (J07BB02) | | | | WHO-DDD | | 30.06.2022 | | 08.08. | | 0.5 ml | | 08.08. | | | | B | | | | Nein | | | | FI | | | | 8.51 | | | | k.A. | | 17.95 | | FB | | | | 7680003730178 | | Impfstoffe | | | | |
| | Zusammensetzung | | haemagglutininum influenzae A (H1N1) A/Brisbane/59/2007 - like A/Brisbane/59/2007 (IVR-148) 15 µg, haemagglutininum influenzae A (H3N3) A/Brisbane/10/2007 -like strain used (A/Uruguay716/2007 (NYMC X-175C) 15 µg, haemagglutininum influenzae B B/Brisbane 60/2008 - like strain: B/Brisbane/60/2008 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, residui: formaldehydum, octoxinolum-9, saccharum, neomycinum, ovalbuminum, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Suspension zur Injektion | | | |
| Wirkstoffe |
|---|
| Vaccinum Influenzae-Split, Inactivatum 2018/2019 |
|
| | Quelle | | | |
|
|
